Ramucirumab

Ramucirumab is a monoclonal antibody medication used to treat certain types of cancer, such as metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. It works by blocking a protein known as VEGFR-2, which helps regulate blood vessel growth. This helps to slow or stop the growth of cancer cells. Ramucirumab is typically used in combination with other medications, such as paclitaxel, to treat advanced cancer. It is administered intravenously.

Ramucirumab, sold under the brand name Cyramza, is a medication used to treat several types of advanced cancer [1, 2]. Here's a closer look at its mechanism of action and applications:

Type of drug:

• Monoclonal antibody: Ramucirumab is a lab-made protein designed to target a specific molecule involved in cancer growth [1].

How it works:

• Targets VEGFR: Ramucirumab binds to a protein called vascular endothelial growth factor receptor (VEGFR), which is found on the surface of some tumor cells [1, 2]. VEGFR plays a crucial role in the development of new blood vessels that supply tumors with nutrients they need to grow.
• Blocks blood vessel growth: By attaching to VEGFR, Ramucirumab hinders the formation of new blood vessels, essentially starving the tumor and slowing its growth [1, 2].

Conditions treated:

• Primarily used for:
  • Advanced stomach cancer [1, 2].
  • Advanced colorectal cancer [1, 2].
  • Advanced non-small cell lung cancer (NSCLC) when other treatments haven't been successful [1, 2].
  • Hepatocellular carcinoma (liver cancer) [2].
• Ramucirumab is usually used in combination with other chemotherapy medications [1, 2].

Benefits:

• May slow or stop the growth of certain cancers [1, 2].
• Can be used when other treatments haven't worked [1, 2].

Important to consider:

• Can cause side effects: Ramucirumab can cause side effects such as high blood pressure, fatigue, nosebleeds, and diarrhea [2].
• Not a cure: Ramucirumab helps manage cancer but doesn't cure it [1, 2].
• Requires intravenous administration: Ramucirumab is given through a vein by a healthcare professional [2].
• Not suitable for everyone: It may not be recommended for people with certain medical conditions or allergies [2].
• Regular monitoring is needed: Your doctor will monitor your blood pressure, blood cell counts, and other health parameters while you receive Ramucirumab [2].